mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |